Paradigm Biocapital Advisors LP

Insider Reports History

Location
New York, NY
Signature
/s/ David Kim, as an authorized signatory of the Fund and the Adviser GP (for itself and on behalf of the Adviser)
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paradigm Biocapital Advisors LP:

Company Role Class Num Shares Value Price $ Report Date Ownership
Olema Pharmaceuticals, Inc. 10%+ Owner Common Stock, par value $0.0001 per share 6,590,981 $76,455,380 $11.60 06 Dec 2023 By: Paradigm BioCapital International Fund Ltd.
Olema Pharmaceuticals, Inc. 10%+ Owner Common Stock, par value $0.0001 per share 4,720,482 $70,405,989 $14.92 01 Aug 2024 By: Paradigm BioCapital International Fund Ltd.
Olema Pharmaceuticals, Inc. 10%+ Owner Common Stock, par value $0.0001 per share 1,312,619 $15,226,380 $11.60 06 Dec 2023 By: One or more separately managed accounts
Olema Pharmaceuticals, Inc. 10%+ Owner Common Stock, par value $0.0001 per share 783,118 $11,680,205 $14.92 01 Aug 2024 By: One or more separately managed accounts

Insider Reports Filed by Paradigm Biocapital Advisors LP

Symbol Company Period Transactions Value $ Form Type Role Filing Time
OLMA Olema Pharmaceuticals, Inc. 01 Aug 2024 2 -$35,796,000 4 10%+ Owner 05 Aug 2024, 16:30
OLMA Olema Pharmaceuticals, Inc. 06 Dec 2023 1 +$1,160,000 4 10%+ Owner 08 Dec 2023, 16:19
OLMA Olema Pharmaceuticals, Inc. 12 Sep 2023 0 $0 3 10%+ Owner 21 Sep 2023, 17:12